Anxo Pharmaceutical Co., Ltd. (TPEX:6677)
Taiwan · Delayed Price · Currency is TWD 18.80
0.00 (0.00%)
Feb 11, 2026, 1:27 PM CST
Anxo Pharmaceutical Revenue
Anxo Pharmaceutical had revenue of 402.78M TWD in the half year ending June 30, 2025, a decrease of -9.53%. This brings the company's revenue in the last twelve months to 883.22M, down -2.90% year-over-year. In the year 2024, Anxo Pharmaceutical had annual revenue of 895.32M, down -4.75%.
Revenue (ttm)
883.22M
Revenue Growth
-2.90%
P/S Ratio
1.19
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 895.32M | -44.62M | -4.75% |
| Dec 31, 2023 | 939.94M | 73.67M | 8.50% |
| Dec 31, 2022 | 866.27M | 42.17M | 5.12% |
| Dec 31, 2021 | 824.10M | -42.01M | -4.85% |
| Dec 31, 2020 | 866.11M | -11.82M | -1.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Excelsior Biopharma | 859.77M |
| Prince Pharmaceutical | 798.27M |
| Winston Medical Supply | 724.35M |
| DV Biomed | 712.61M |
| GeneFerm Biotechnology | 654.88M |
| Tien Liang BioTech | 467.02M |
| General Biologicals | 251.38M |
| Mediera | 240.30M |